Gulf Resources, Inc. — FY2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual report, not a standalone fourth-quarter report. Gulf Resources operates through subsidiaries in China and reports in U.S. dollars; its operating subsidiaries use the RMB as their functional currency.
Business context
The company produces and sells bromine and crude salt, primarily in Shandong, China. Its chemical-products facilities remain closed during relocation, and its Sichuan natural-gas project remains suspended pending approvals. Bromine and crude salt accounted for nearly all FY2022 revenue.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $66.09 million | $55.03 million |
| Gross profit / margin | $37.43 million / 57% | $27.90 million / 51% |
| Operating income | $16.48 million | $5.21 million |
| Income before tax | $16.65 million | $5.37 million |
| Income tax expense | $6.59 million | $6.30 million |
| Net income (loss) | $10.06 million | $(0.92) million |
| Operating cash flow | $51.15 million | $23.31 million |
| Investing cash flow | $(37.56) million | $(30.09) million |
- Bromine revenue was $58.96 million, up 21%, reflecting 6% higher volume and a 14% higher average selling price. Crude-salt revenue was $7.00 million, up 15%, mainly from higher prices and slightly higher volume.
- Gross margin improved to 57% from 51%. Management attributed the earnings improvement primarily to higher sales and prices, better margins, and lower general and administrative costs; those costs declined 37%, partly because FY2021 included larger stock-grant expense.
- Cash and cash equivalents were $108.23 million, up from $95.77 million. Current assets were $119.43 million and current liabilities $11.78 million. The company said cash and operating cash flows should cover anticipated needs for the next 12 months.
- Total liabilities were $20.81 million; these included $9.68 million of finance- and operating-lease liabilities. The balance sheet reports no significant conventional borrowing. Cash was held at PRC financial institutions and was not insured or otherwise protected, according to the filing.
- Capital expenditures were $37.56 million. The filing lists $15.69 million of capital-expenditure commitments, including $14.70 million due within 12 months. Total assets were $292.43 million, down from $309.86 million, while shareholders’ equity was $271.62 million.
- Foreign-currency translation produced a $24.89 million comprehensive loss, compared with a $7.41 million gain in FY2021. This substantially reduced reported equity in U.S.-dollar terms.
Material changes, outlook and risks
- Factory No. 8 resumed production in August 2022 and contributed revenue in the fourth quarter. Factories No. 2 and No. 10 still lacked government approval. Operating bromine facilities were temporarily closed under a citywide order from December 10, 2022 through February 1, 2023, then reopened as planned.
- The chemical factory relocation is estimated to cost about $64 million; $45.58 million had been incurred by year-end 2022. Equipment delivery and installation had been delayed. Management discussed testing and possible trial production by late 2023 or early 2024, but the subsequent-event note describes further steps and approvals before commercial production; timing remains uncertain.
- The natural-gas and brine project in Sichuan remains halted pending project, safety, environmental, land, exploration and mining approvals. No natural-gas revenue was reported in either year.
- Management stated that excluding certain nonrecurring or non-operational items and $5.32 million of impairments and write-offs, FY2022 net income would have been $15.38 million. The filing text does not provide a clear reconciliation of this adjustment to reported results.
- Material risks include dependence on Chinese government permissions and environmental and safety compliance; unresolved land-use matters; customer and supplier concentration; foreign-exchange and capital-transfer restrictions; and potential future PCAOB inspection or HFCAA-related trading restrictions. The filing says the PCAOB obtained complete access to inspect China-based firms in 2022, while noting future access remains uncertain.
- A 2018 land-use enforcement matter involving six factories sought land return, restoration or demolition and penalties of approximately RMB 1.3 million. The company considered enforcement and material losses remote and recorded no related accrual; it cautioned that further enforcement could cause liabilities or disruption.
- The company reported no cash dividends and does not expect to pay them in the foreseeable future. Its auditor issued an unqualified opinion on the financial statements; the auditor identified property, plant and equipment as a critical audit matter. The auditor did not attest to internal-control effectiveness; management concluded controls were effective.
Important facts for investors to verify
- Whether approvals for Factories No. 2 and No. 10 are obtained, and whether Factory No. 8 sustains production.
- The remaining cost, equipment schedule, required approvals and realistic commercial-start date for the chemical factory relocation.
- The status and potential financial or operating consequences of the land-use enforcement decisions and related property documentation.
- The reconciliation of management’s adjusted $15.38 million net-income figure to audited net income of $10.06 million, and the stated $5.32 million of impairments and write-offs.
- Cash availability for capital commitments, including where cash is held, any transfer restrictions, and the concentration of sales among customers and raw-material purchases among suppliers.
- Future PRC regulatory requirements and PCAOB inspection access that could affect operations, overseas filings or Nasdaq listing status.